Evidence map›Paper›PMID 33339816›Full record

ArticleNature communications2020

Single-cell atlas of the first intra-mammalian developmental stage of the human parasite Schistosoma mansoni.

Carmen Lidia Diaz Soria, Jayhun Lee, Tracy Chong, Avril Coghlan, Alan Tracey, Matthew D Young, Tallulah Andrews, Christopher Hall, Bee Ling Ng, Kate Rawlinson and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cross-reactivity and localization of Schistosoma mansoni antigen for immunodiagnosis.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Analysis ofComputational and structural biotechnology journal · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Carmen Lidia Diaz SoriaWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.ORCID 0000-0003-1793-1074
Jayhun LeeRegenerative Biology, Morgridge Institute for Research, Madison, WI, USA.ORCID 0000-0003-3967-3424
Tracy ChongRegenerative Biology, Morgridge Institute for Research, Madison, WI, USA.
Avril CoghlanWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.ORCID 0000-0002-2775-5951
Alan TraceyWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.ORCID 0000-0002-4805-9058
Matthew D YoungWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.
Tallulah AndrewsWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.ORCID 0000-0003-1120-2196
Christopher HallWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.ORCID 0000-0001-6156-4975
Bee Ling NgWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.ORCID 0000-0002-8338-4390
Kate RawlinsonWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.ORCID 0000-0001-8297-8405
Stephen R DoyleWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.ORCID 0000-0001-9167-7532
Steven LeonardWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.
Zhigang LuWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.ORCID 0000-0001-6553-5944
Hayley M BennettWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.ORCID 0000-0001-8879-2855
Gabriel RinaldiWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK. gr10@sanger.ac.uk.ORCID 0000-0002-7767-4922
Phillip A NewmarkRegenerative Biology, Morgridge Institute for Research, Madison, WI, USA. PNewmark@morgridge.org.ORCID 0000-0003-0793-022X
Matthew BerrimanWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK. mb4@sanger.ac.uk.ORCID 0000-0002-9581-0377
Wellcome Sanger Institute · GBHoward Hughes Medical Institute · US

Funding

Howard Hughes Medical InstituteNIAID NIH HHS HHSN272201700014CWellcome Trust 107475/Z/15/ZWellcome Trust 206194
6 · The paper itself

Abstract

Over 250 million people suffer from schistosomiasis, a tropical disease caused by parasitic flatworms known as schistosomes. Humans become infected by free-swimming, water-borne larvae, which penetrate the skin. The earliest intra-mammalian stage, called the schistosomulum, undergoes a series of developmental transitions. These changes are critical for the parasite to adapt to its new environment as it navigates through host tissues to reach its niche, where it will grow to reproductive maturity. Unravelling the mechanisms that drive intra-mammalian development requires knowledge of the spatial organisation and transcriptional dynamics of different cell types that comprise the schistomulum body. To fill these important knowledge gaps, we perform single-cell RNA sequencing on two-day old schistosomula of Schistosoma mansoni. We identify likely gene expression profiles for muscle, nervous system, tegument, oesophageal gland, parenchymal/primordial gut cells, and stem cells. In addition, we validate cell markers for all these clusters by in situ hybridisation in schistosomula and adult parasites. Taken together, this study provides a comprehensive cell-type atlas for the early intra-mammalian stage of this devastating metazoan parasite.

Indexed as

Single-Cell AnalysisAnimalsEsophagusExonsGene Expression RegulationHumansMammalsMuscle CellsNervous SystemNeuronsParasitesSchistosoma mansoniStem CellsTranscription, Genetic

Identifiers

PMID33339816
PMCPMC7749135
OpenAlexW3117082754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.